Home›Companies›Biotech & Pharma›Sentire Medical Systems

Sentire Medical Systems, Inc.

Updated Oct 29, 2026·Latest SEC filing Feb 4, 2026·Suggest an edit

About Sentire Medical Systems

Sentire Medical Systems is a private company based in Palm Beach Gardens, Florida. It has reported $1,767,544 raised in two offerings on Form D since January 2018. Its chief executive is David Krasne.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 15, 2025Feb 4, 2026$1,167,544of $1.2M target9$129KEquity, Simple Agreement for Future Equity (SAFE)Rule 506(c)Form D ↗
Jan 8, 2018Jan 19, 2018$600,000of $700K target3$200KEquityRule 506(b)Form D ↗
Total, two offerings$1,767,544

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Sentire Medical Systems's Form D filed Feb 4, 2026.

DK
David Krasne
CEO and director

Earlier filings also listed Peng Cheng (director, last listed Jan 2018) and Jonathan Diamond (director, last listed Jan 2018).

Sources

  1. SECSentire Medical Systems, Inc. filing history